The Urine Balance Test aims at detecting alterations of the Th1/Th2 balance. Modulation of the Th1/Th2 balance may affect the susceptibility to, or the outcome of infections, allergic diseases, auto-immunity, cancer and other deleterious conditions. The UBT test may detect disturbances of this delicate equilibrium in time in order to restore balance whenever required and before irreversible conditions are developing. The test allows patients to follow-up on Th1/Th2 balance during therapy and to evaluate whether the treatment he or she is undergoing is really effective. In addition the test also provides a tool to check the effectiveness of over the counter sold products claiming to balance Th1/Th2 status such as: anti-oxidants, probiotics and other. Thus far Th1/Th2 profiles can only be determined in specialized laboratories. These analyses are blood-based and practically are hard to be performed repeatedly over short periods of time. In summary, the UBT test is a simple "self-test" allowing to determine personal Th1/Th2 profiles repeatedly over short time periods and to follow-up on the effect of therapy, intake of drugs and nutraceuticals or any other strategy to balance Th1/Th2 states.
Self-test monitoring of the Th1/Th2 balance in health and disease with special emphasis on chronic fatigue syndrome/myalgic encephalomyelitis. Journal of Medical Laboratory and Diagnosis Vol. 3(1), pp. 1- 6, February 2012.
Assays developed by PROTEA biopharma are commercialized on a fee-per-service basis by R.E.D Laboratories (www.redlabs.com). The Urine Th1/Th2 Balance Test is a simple urine test based on our most recent research achievements. This assay will be available as point-of-care test; it will be commercialized first as a research test, through this website, and then through pharmacies or health-care centers. This will allow self-testing of the patients and easy follow-up on therapy.
An overview of the test procedure is provided in the following information leaflet. This leaflet is also a standard part of the kit.